Form 4: Dynavax Director Elaine Sun Reports Stock and Option Transactions

Sentiment:

SEC Form 4 Filing


Director Elaine Sun reports acquisition of restricted stock units and stock options in Dynavax Technologies Corp.

Summary

  • On May 23, 2024, Elaine Sun, a director of Dynavax Technologies Corp., reported acquiring 5,357 shares of common stock and 22,500 stock options.
  • The common stock was acquired at a price of $0.
  • The stock options have an exercise price of $11.85 and expire on May 22, 2031.
  • These securities are restricted stock units (RSUs), each representing a contingent right to receive one share of DVAX Common Stock.
  • The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date.
  • The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company.
  • The option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date.
  • Following the reported transactions, Sun beneficially owns 24,107 shares of common stock and 22,500 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock and option transactions by a company director. The acquisitions could be interpreted as a positive sign of confidence, but it's not definitively bullish.

Positives

  • The acquisition of stock and options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The RSUs vest in one year, contingent on continued service, and the stock options also vest in one year, contingent on continued service.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates changes in the holdings of a Dynavax director.

Stakeholder Impact

  • The transactions may have a minor impact on shareholder sentiment, potentially viewed as a positive signal due to the director's increased stake in the company.

Key Dates

DateDescription
05/23/2024Date of transaction: acquisition of common stock and stock options.
05/22/2031Expiration date of the stock options.
05/28/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.